GSK has been the subject of several other research reports. About 2.22 million …
On July 14 the stock rating was upgraded from “” to “Buy” in a report issued by Jefferies. On February 26 analysts at Cantor Fitzgerald started covering GSK with a rating of “Hold”. On January 27, 2016 the stock rating was set at “Buy ...
Drugmaker's shares down 5.6 pct at $43 premarket ** Ionis says it retains all rights of 2 drugs after GlaxoSmithKline declines its options ... Ionis COO Lynne Parshall ** Up to Thursday's close, stock had fallen 4.7 pct YTD Get latest …
The stock index had dropped to a 16-day low on Wednesday as ... These were followed by Universal Press Plc, Berger Paints Plc and GlaxosmithKline
ICICI Direct recommended buy rating on GSK Consumer with a target price of Rs 5960 in its research report dated August 11, 2017. Amid de-stocking ahead of …
Brandes Investment Partners LP now owns 3,363,788 shares of the pharmaceutical company's stock valued at $141,817,000 after buying an additional 214,167 shares during the last quarter. Regentatlantic Capital LLC purchased a …
GSK and Ionis have worked together since 2010 to find and develop ... Ionis investors appeared to share that optimism. While the drugmaker's stock was initially down about 4% to $43.83 per share at market's open Friday, it rallied back up …